|
RGNX
|
REGENXBIO Inc.
|
0.75%
|
US
|
NASDAQ
|
|
IGMS
|
IGM Biosciences, Inc.
|
0.75%
|
US
|
NASDAQ
|
|
CRSP
|
CRISPR Therapeutics AG
|
0.75%
|
US
|
NASDAQ
|
|
ARWR
|
Arrowhead Research Corporation
|
0.75%
|
US
|
NASDAQ
|
|
SGMO
|
Sangamo BioSciences, Inc.
|
0.74%
|
US
|
NASDAQ
|
|
RVMD
|
Revolution Medicines, Inc.
|
0.74%
|
US
|
NASDAQ
|
|
REPL
|
Replimune Group, Inc.
|
0.74%
|
US
|
NASDAQ
|
|
PGEN
|
Precigen, Inc.
|
0.74%
|
US
|
NASDAQ
|
|
MRTX
|
Mirati Therapeutics, Inc.
|
0.74%
|
US
|
NASDAQ
|
|
IOVA
|
Iovance Biotherapeutics, Inc.
|
0.74%
|
US
|
NASDAQ
|
|
AFMD
|
Affimed Therapeutics B.V.
|
0.74%
|
US
|
NASDAQ
|
|
QURE
|
uniQure N.V.
|
0.73%
|
US
|
NASDAQ
|
|
PRTA
|
Prothena Corporation plc
|
0.73%
|
US
|
NASDAQ
|
|
KURA
|
Kura Oncology, Inc.
|
0.73%
|
US
|
NASDAQ
|
|
DNLI
|
Denali Therapeutics Inc.
|
0.73%
|
US
|
NASDAQ
|
|
ATRA
|
Atara Biotherapeutics, Inc.
|
0.73%
|
US
|
NASDAQ
|
|
NGM
|
NGM Biopharmaceuticals, Inc.
|
0.73%
|
US
|
NASDAQ
|
|
IMTX
|
Immatics N.V.
|
0.72%
|
US
|
NASDAQ
|
|
DVAX
|
Dynavax Technologies Corporation
|
0.72%
|
US
|
NASDAQ
|
|
ARQT
|
Arcutis Biotherapeutics, Inc.
|
0.71%
|
US
|
NASDAQ
|